Clinical trial Recruiting at 1 site Interventional Ages 11 to 15

Understanding weight regain in youth with obesity

Official title: Adaptive Mechanisms Responsible for Weight Change in Youth With Obesity

Run by Ann & Robert H Lurie Children's Hospital of Chicago · NCT05125822 · Data updated 2026-11-12

This study is testing how meal replacement therapy and counseling can help young people who have lost weight understand and prevent regaining it by looking at the role of hormones.

Quick facts

Study typeInterventional
Ages11 Years to 15 Years
SexAll
Enrollment260 (estimated)
SponsorAnn & Robert H Lurie Children's Hospital of Chicago
Academic / other
Locations1 site (Chicago, Illinois)
StatusRecruiting
StartedAugust 26, 2023
Main results expectedJanuary 1, 2028
Study endsJanuary 1, 2028
Registry record updatedJune 2, 2026
Trial IDNCT05125822 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are youth aged 11 to less than 16 years with a BMI over 30 kg/m² or at the 95th percentile.

Probably not a fit

Patients with certain medical conditions, such as diagnosed eating disorders or those who have had prior bariatric surgery, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the reasons behind weight regain in youth who have lost weight, focusing on the role of hormones. Participants will undergo an 8-week meal replacement therapy, consuming shakes and frozen meals while adhering to a calorie-controlled diet. They will also receive bi-weekly lifestyle and behavioral modification counseling to support their weight loss efforts. The study will track compliance through dietary logs and assess the effectiveness of the interventions over a 35-week period.

Why it matters

Potential benefit: If successful, this study could provide insights into effective weight management strategies for youth with obesity.

How similar studies have gone: Other studies have shown success in using meal replacement and behavioral modification for weight management, indicating a promising approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 11 to less than 16 years old
* BMI \> 30 kg/m\^2 or 95th BMI percentile
* Tanner stage 2, 3, or 4

Exclusion Criteria:

* Tanner stage 1 and 5
* Prior bariatric surgery
* Current or recent (\< 3 months prior to enrollment) use of anti-obesity medication(s) defined as orlistat, metformin, phentermine, topiramate, combination phentermine/topiramate, liraglutide, and/or combination naltrexone/bupropion (monotherapy use of naltrexone or bupropion is not an exclusion)
* Monogenic and hypothalamic obesity
* Polycystic ovary syndrome (diagnosed by a physician)
* Pregnancy or planned pregnancy
* Current use of supplemental hormones
* Individuals with a diagnosed eating disorder of anorexia nervosa, bulimia or binge eating disorder
* Type 1 or 2 diabetes
* Treatment with growth hormones
* Thyroid disease/problem
* Has had cancer in the last 10 years

Where it's running

  • Ann & Robert H Lurie Children's Hospital of Chicago
    Chicago, Illinois, United States
    Recruiting

Study contacts

  • Principal investigator: Justin Ryder, PhD — Ann & Robert H Lurie Children's Hospital of Chicago
  • Study coordinator: Justin Ryder, PhD
  • Email: jryder@luriechildrens.org
  • Phone: 3148826838

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Progressive Neuromuscular Stabilization vs. Aerobic Exercise for Obesity in Children

    This study tests whether technology-assisted progressive neuromuscular stabilization exercises can improve body composition and balance in children with obesity, compared with standard aerobic exercise.

    Recruiting Istanbul University - Cerrahpasa · Istanbul · NCT07744022

  • MRI study to see how obesity treatments affect body and organ fat in severely obese kids

    This study tests whether adding a GLP-1 receptor agonist to lifestyle changes helps improve body composition and organ fat in adolescents with severe obesity.

    Recruiting Alder Hey Children's NHS Foundation Trust · Liverpool, Merseyside · NCT07702825

  • Bottle flow-rate test for babies and feeding patterns

    This study tests whether different bottle nipple flow rates affect how much milk a 4–6 month old infant drinks, how they feed, and their sleep, by watching 220 mother–infant pairs.

    Recruiting University of Michigan · Ann Arbor, Michigan · NCT07665983

  • Mountain West Family Healthy Weight Program

    This project will test whether text message outreach and direct enrollment in a community healthy‑weight program help lower‑income families with a 5–12 year old child with obesity sign up for and stay engaged in the program.

    Recruiting University of Utah · Salt Lake City, Utah · NCT07479498

  • Exercise after pregnancy to activate infant brown fat

    This study will test if a mother's exercise during pregnancy and after birth changes her breast milk so it increases her infant's brown fat activity and energy use.

    Recruiting at 2 sites Joslin Diabetes Center · Boston, Massachusetts and 1 other locations · NCT07467694

  • Phentermine to help teens with obesity

    This Phase IIb trial will test whether 16 mg of phentermine daily can help overweight adolescents aged 12 to under 18 compared with placebo over a year.

    Recruiting at 8 sites Phase 2 Heartland DCOC · Wilmington, Delaware and 7 other locations · NCT07282340

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.